Concepedia
Statistics
Publications
26
Citations
1.6K
H-Index
20
Active since
1985
Affiliations
AstraZeneca (United Kingdom)(Current)
AstraZeneca (United States)
AstraZeneca (Brazil)
Peterborough City Hospital
AstraZeneca (Singapore)
Chris Womack is an author at AstraZeneca (United Kingdom) specializing in medicine, oncology, and molecular oncology.
Publications per year
1985–2020
Vascular Endothelial Growth Factor Receptors VEGFR-2 and VEGFR-3 Are Localized Primarily to the Vasculature in Human Primary Solid Cancers
Neil R. Smith, Dawn Baker, Neil H. James et al. · Clinical Cancer Research · 2010 · 237 citations · Full text
Medicine, Cancer Biology, Oncology +16
Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes
Darren Hodgson, Brian Dougherty, Zhongwu Lai et al. · British Journal of Cancer · 2018 · 232 citations · Full text
Medicine, Molecular Genetics, Oncology +17
FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study
Xin Su, Ping Zhan, Paul R. Gavine et al. · British Journal of Cancer · 2014 · 188 citations · Full text
Medicine, Oncology, Pathology +15
Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy
Neil R. Smith, Dawn Baker, Matthew R. Farren et al. · Clinical Cancer Research · 2013 · 136 citations · Full text
Medicine, Cancer Biology, Oncology +17
Antibody validation of immunohistochemistry for biomarker discovery: Recommendations of a consortium of academic and pharmaceutical based histopathology researchers
William Howat, Arthur Lewis, Phillipa Jones et al. · Methods · 2014 · 103 citations · Full text
Pharmacy, Pathology, Antibody Engineering +16
1–5 of 26